By Gavin Yamey, MD, MPH
In the summer of 2025, the Kiel Institute, a non-profit think tank based in Germany, commissioned a comprehensive analysis into the global return on investment for international health aid. The goal was to quantify the efficacy of multilateral programs like the Global Fund, the President’s Emergency Plan for AIDS Relief (PEPFAR), and Gavi, the Vaccine Alliance. My team at Duke University’s Center for Policy Impact in Global Health embarked on a rigorous review of medical literature, economic datasets, and expert interviews.
What we found was a compelling, evidence-backed narrative: international health aid is not merely an act of charity; it is a strategic investment in global security. Yet, as our analysis matured, we were confronted with a jarring reality. While the world watched nations like the U.S., Germany, and France slash their health budgets, we observed a direct correlation between these fiscal retreats and a surge in preventable mortality across low- and middle-income countries (LMICs).
The tragedy is not just the humanitarian cost—which is immense—but the profound strategic error of donor nations failing to recognize that health security is a "mutual benefit" enterprise.
The Economics of Mutual Benefit
The prevailing misconception among modern political factions is that foreign aid is a drain on domestic resources. Our research indicates the exact opposite. Every dollar invested in pandemic prevention and response is estimated to yield $14 in long-term health and economic returns.
When donor nations invest in the health of LMICs, they are essentially building a global firewall against biological threats. Pandemics, by definition, ignore national borders. By fortifying healthcare infrastructure in the Global South, nations protect themselves from the importation of deadly pathogens. Furthermore, these investments combat antimicrobial resistance—a quiet, global pandemic that threatens to render modern surgery and basic medicine obsolete.
Beyond biology, there is the matter of "soft power." Studies of PEPFAR and the U.S. President’s Malaria Initiative have consistently shown that targeted health aid significantly improves international perceptions of the donor nation. When the U.S. retreats, it creates a geopolitical vacuum often filled by rivals, while simultaneously dismantling the R&D pipelines that fuel domestic innovation, job creation, and industrial growth in the biotech and pharmaceutical sectors.
Chronology of a Dismantling: The 2025-2026 Collapse
The retreat from global health was not merely a budgetary adjustment; it was a systemic dismantling of the American public health apparatus.
The Musk-Kennedy Era of Efficiency
In early 2025, the newly formed Department of Government Efficiency (DOGE), led by Elon Musk, targeted the United States Agency for International Development (USAID) for total elimination. In a series of inflammatory posts on X, Musk signaled the end of decades of development infrastructure, boasting about "feeding USAID into the wood chipper."
Simultaneously, HHS Secretary Robert F. Kennedy Jr. oversaw a mass exodus of institutional knowledge at the Centers for Disease Control and Prevention (CDC). Hundreds of career experts—veteran epidemiologists, virologists, and "disease detectives"—were terminated. The administration froze $600 million in congressionally appropriated funds meant for Gavi, effectively halting vaccine distribution efforts that were vital for maternal and child health.
The War on Technology and Science
Perhaps most baffling was the administration’s hostility toward mRNA technology. Despite its proven success in mitigating the COVID-19 pandemic, Secretary Kennedy moved to end federal support for mRNA R&D. NIH Director Jay Bhattacharya provided the intellectual cover for this pivot, authoring pieces that public health experts widely condemned as anti-scientific.
The administration’s ideological shift reached a nadir when the NIH deputy director and Bhattacharya co-authored an editorial suggesting that the U.S. should abandon the pursuit of pandemic preparedness in favor of "individual health optimization." This rhetoric, which mirrors the dangerous historical tropes of eugenics, signaled a total abandonment of the social contract regarding public health.
Supporting Data: The Cost of Withdrawal
The evidence of the impact of these policies is already surfacing in the morbidity and mortality data of the last eighteen months:
- WHO Funding Gap: Following the U.S. withdrawal from the World Health Organization—leaving behind an unpaid debt of $260 million—the organization was forced to reduce its workforce by approximately 25%. This has severely hampered global surveillance capabilities.
- Surveillance Lag: Because the U.S. is no longer a member of the WHO, communication channels have atrophied. During the recent Ebola outbreak in the Democratic Republic of Congo and Uganda, U.S. intelligence agencies received critical information nine days later than the WHO’s member nations.
- Infrastructure Collapse: The USAID-funded laboratories and surveillance networks in Central Africa—once the frontline of global outbreak detection—have ceased operations. The result is a total loss of the "early warning system" that historically protected the U.S. from emerging zoonotic diseases.
Official Responses and the "Eugenics" Critique
The administration’s internal defense has been characterized by a rejection of internationalism. Officials argue that the U.S. should focus solely on "border-centric" protection, a policy that assumes a virus can be stopped at a customs checkpoint.
However, the medical community has pushed back fiercely. Public health leaders, including the Lancet commission, have pointed to the 25 million deaths caused by the COVID-19 pandemic as a warning of what happens when global coordination fails. The administration’s move to gut the White House Office for Pandemic Response Policy suggests an intentional choice to leave the nation—and the world—unprepared for the "next big one." Experts currently estimate a greater than 50% chance of a pandemic of similar magnitude to COVID-19 within the next 25 years.
The Strategic Implications: A Lose-Lose Scenario
The retreat from global health is, by any objective metric, a self-inflicted wound of historic proportions. The U.S. government has traded its role as a global stabilizer for a short-term, isolationist ideology that leaves it blind to emerging threats.
Implications for Global Security
Without the CDC’s disease detectives on the ground, the U.S. has no "eyes and ears" in the most dangerous hotspots for viral mutation. We are reverting to a pre-globalization model of health, where we wait for a virus to reach our own cities before we acknowledge its existence. This is not "America First"; it is "America Last."
Implications for Economic Stability
The collapse of global health R&D partnerships means that the next generation of vaccines, diagnostics, and therapeutics will not be pioneered by American firms. By breaking the cycle of investment that has historically allowed the U.S. to lead in medical technology, the administration is effectively ceding the future of the multi-trillion-dollar health economy to other nations.
The Human Cost
Ultimately, the most damning evidence is the human one. The increase in maternal mortality and the resurgence of infectious diseases that were once on the path to elimination are the direct result of a policy failure. The "mutual harms" we predicted in our Kiel Institute analysis have manifested. By withdrawing from the international stage, the U.S. has not gained safety; it has created a more volatile, more infectious, and less stable world.
As we look toward the future, the question is not whether another pandemic will occur, but whether the infrastructure to stop it will exist when it arrives. If the current trend of isolationism and scientific denialism continues, we are not just witnessing the end of American global leadership in health—we are witnessing the beginning of a new, darker era of global insecurity. The cost of this retreat will be measured in years, dollars, and, most tragically, in the lives of millions who could have been saved.
